Copyright
©The Author(s) 2015.
World J Gastroenterol. Jan 7, 2015; 21(1): 155-163
Published online Jan 7, 2015. doi: 10.3748/wjg.v21.i1.155
Published online Jan 7, 2015. doi: 10.3748/wjg.v21.i1.155
Figure 3 Vasoactive intestinal peptide in plasma after trinitrobenzene sulfonic acid treatment.
Plasma concentration of vasoactive intestinal peptide (VIP) was assessed in naïve animals and after trinitrobenzene sulfonic acid (TNBS) treatment at the 2-h and 14-d time-points using a peptide enzyme immunoassay. n = 4 for all conditions, aP < 0.05 vs controls; ANOVA with Dunnett’s posttests.
- Citation: Del Valle-Pinero AY, Sherwin LB, Anderson EM, Caudle RM, Henderson WA. Altered vasoactive intestinal peptides expression in irritable bowel syndrome patients and rats with trinitrobenzene sulfonic acid-induced colitis. World J Gastroenterol 2015; 21(1): 155-163
- URL: https://www.wjgnet.com/1007-9327/full/v21/i1/155.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i1.155